We previously proposed a clinical state of metastasis termed'oligometastases' that refers to
restricted tumor metastatic capacity. The implication of this concept is that local cancer …

Clinical reports of limited and treatable cancer metastases, a disease state that exists in a
transitional zone between localized and widespread systemic disease, were noted on …

PURPOSE: To analyze the long-term survival and tumor control outcomes after stereotactic
body radiotherapy (SBRT) for metastases limited in number and extent. METHODS AND …

Objectives Long-term survival has been observed in patients with oligometastatic non-small
cell lung cancer (NSCLC) treated with locally ablative therapies to all sites of metastatic …

BACKGROUND: A subset of patients with metastatic cancer in limited organs may benefit
from metastasis‐directed therapy. The authors investigated whether patients with limited …

Background The aim of this analysis was to model the effect of local control (LC) on overall
survival (OS) in patients treated with stereotactic body radiotherapy (SBRT) for liver or lung …

Background Stereotactic ablative radiotherapy (SABR) has emerged as a new treatment
option for patients with oligometastatic disease. SABR delivers precise, high-dose …

PURPOSE: To assess the safety and effectiveness of percutaneous cryoablation to treat
limited metastases to the musculoskeletal system, with the goal of complete disease …

PURPOSE: To report tumor local control after treatment with single-dose image-guided
intensity-modulated radiotherapy (SD-IGRT) to extracranial metastatic sites. METHODS AND …

Postoperative recurrence occurs in approximately half of patients with non-small cell lung
cancer (NSCLC), even after complete resection. Disease recurrence after surgical resection …